ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 507

Comparison of Body Mass Index, Anti-Citrullinated Peptides Antibodies Status and Periodontal Condition in First Degree Relatives Individuals to Rheumatoid Arthritis

Sonia Unriza-Puin1, Wilson Bautista-Molano2,3, Gloria Lafaurie4, Rafael R. Valle-Oñate5, Phillipe Chalem6, Lorena Chila3, Juan Manuel Bello7 and Consuelo Romero Sanchez3,8, 1Unit of Oral Basic Investigation, School of Dentistry, Universidad El Bosque, Bogota, Colombia, 2Rheumatology Department School of Medicine HMC / UMNG, Bogotá, Colombia, 3Unit of Oral Basic Investigation, School of Dentistry, Universidad El Bosque, Bogotá, Colombia, 4Unit of Oral Basic Investigation-UIBO, School of Dentistry, Universidad El Bosque, Bogotá, Colombia, 5Rheumatology, Rheumatology Department School of Medicine HMC / UMNG, Bogota, Colombia, 6Fundación Instituto de Reumatología Fernando Chalem, Bogotá, Colombia, 7Rheumatology Department School of Medicine HMC / UMNG, Bogota, Colombia, 8Rheumatology, School of Medicine HMC / UMNG, Bogota, Colombia

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: anti-CCP antibodies, obesity and rheumatoid arthritis (RA), Periodontitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  Association studies in rheumatoid arthritis (RA) have been focused in the pre-clinical phases of the disease in asymptomatic individuals with higher risk to develop RA such as first-degree relatives (FDR). Previous data has shown that obesity, the anti-citrullinated peptides antibodies (ACPA) status and the periodontal condition may modulate the severity and the clinical presentation of RA. The objective of this study were to investigate the body mass index (BMI), ACPA status, the frequency and severity of periodontal disease and the level of antibodies IgG-1, IGG-2 against P. gingivalis in healthy FDR individuals of RA-patients and compare these variables with a control group of healthy individuals from general population.

Methods:  In total, 100 FDR individuals and 200 healthy controls paired by age and gender were included. Rheumatologic and periodontal assessment was performed as well as anti-P gingivalisantibodies and ACPA. The group-comparisons were analyzed using McNemar and Wilcoxon tests. A conditional logistic regression analyses was performed to establish associations between BMI, ACPA status and periodontitis in FDR individuals and control group.

Results:  In the FDR-group, seventy percent were female with a mean age of 37.3±13 years. In the FDR-group 17% had obesity (BMI>30), compared to 7.5% in the control group. Additionally, there was association related to the presence of obesity in the FDR group (OR: 2.9, 95% CI 1.03-8.28). ACPA presence was found in 7% in FDR vs 2.5 % in control group (p=0.038), and was associated in the FDR group (OR: 2.4, 95% CI 0.7- 8.32). In the FDR-group 79% had periodontitis in comparison with control group 56% (p=0.001). Fifty percent of severe periodontitis was observed in FDR vs 9% in control group (p=0.009). A significant association was found in FDR individuals regarding the presence of periodontitis (OR: 3.95% CI 1.89–7.29). Results presented in Table 1. Regarding the presence of antibodies anti P. gingivalis(IgG1-IgG2) and smoking history, no differences between groups were found.

Conclusion:  Obesity, ACPA expression and periodontitis (diagnosis and severity) can be considered as relevant risk factors associated to the development of RA in individuals FDR. The impact of interdisciplinary management, weight-loss interventions, recommendations on physical activity and screening of periodontal status in asymptomatic individuals at high-risk of developing RA such as FDR, should be further investigated. Table 1. Conditional logistic regression model for indicators related to the status of first-degree relatives of patients with RA (Obesity, ACPA, Periodontitis Diagnosis and adjusted Age)

Unadjusted model

Adjusted model

OR

CI 95%

OR

CI 95%

Obesity (BMI≥30)

2.93

1.03 – 8.28

2.37

0.28 – 19.84

ACPA IgG-IgA (≥20 U)

2.45

0.72 – 8.32

11.82

0.07 – 1819.30

Periodontitis

3.70

1.88 – 7.29

7.63

1.07 – 54.30

Age

0.53

0.34 – 0.83

0.53

0.34 – 0.84

Periodontitis based on definition of CDC/AAP. Age = continuous Unadjusted model = includes ACPAs IgG/IgA, periodontitis, obesity and age Adjusted Model = includes ACPAs IgG-IgA, periodontitis, obesity, age and interaction of ACPAs IgG-IgA and Periodontitis with age and obesity


Disclosure: S. Unriza-Puin, None; W. Bautista-Molano, None; G. Lafaurie, None; R. R. Valle-Oñate, None; P. Chalem, None; L. Chila, None; J. M. Bello, None; C. Romero Sanchez, None.

To cite this abstract in AMA style:

Unriza-Puin S, Bautista-Molano W, Lafaurie G, Valle-Oñate RR, Chalem P, Chila L, Bello JM, Romero Sanchez C. Comparison of Body Mass Index, Anti-Citrullinated Peptides Antibodies Status and Periodontal Condition in First Degree Relatives Individuals to Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/comparison-of-body-mass-index-anti-citrullinated-peptides-antibodies-status-and-periodontal-condition-in-first-degree-relatives-individuals-to-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-body-mass-index-anti-citrullinated-peptides-antibodies-status-and-periodontal-condition-in-first-degree-relatives-individuals-to-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology